Adam Havey, EVP, Business Operations at Emergent BioSolutions Inc. (EBS), sold 15,770 shares at $37.06 ($584K) on 2017-09-08, disclosed to the SEC on 2017-09-12.
Open-market sale of $584k EBS by EVP, Business Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.06 | 7,885 | $292K | 50.0% |
| 2 | $37.06 | 7,885 | $292K | 50.0% |
| Total | $37.06 avg | 15,770 | $584K | 100% |
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |